RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors.

Autor: Xuesong Zhao1,2, Ponomaryov, Tatyana1,2,3, Ornell, Kimberly J.1,2, Pengcheng Zhou1,2, Dabral, Sukriti K.1,2, Pak, Ekaterina1,2, Wei Li4, Atwood, Scott X.5, Whitson, Ramon J.5, Chang, AnneLynn S.5, Jiang Li5, Oro, Anthony E.5, Chan, Jennifer A.6, Kelleher, Joseph F.7, Segal, Rosalind A.1,2 rosalind_segal@dfci.harvard.edu
Zdroj: Cancer Research. 9/1/2015, Vol. 75 Issue 17, p3623-3635. 13p.
Databáze: Academic Search Ultimate